BEUDAMED
    FDA Adverse Event Injury Summary report: N

    HEPARIN

    MDR report key: 1080833 · Received July 22, 2008

    Report

    Report Number
    MW5007738
    Event Type
    Injury
    Date Received
    July 22, 2008
    Date of Event
    August 2, 2007
    Report Date
    December 18, 2007
    Product Code
    NZW
    Report Source
    Voluntary report
    Reporter Location
    TN, US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    NARRATIVE: PT WITH NORMAL PLATELET COUNT 2007 (125,000) HAD BEEN RECEIVING TICARCILLIN 3.1G Q6H SINCE ABOUT 13 DAYS PRIOR, WITH HEPARIN FLUSHES BETWEEN DOSES THROUGH HIS CENTRAL LINE. HE REC'D ONE DOSE OF ENOXAPARIN 40MG ABOUT 2 DAYS LATER, AND THEN WAS NOTED TO HAVE A LOW PLATELET COUNT OF 39,500 IN THE NEXT DAY. HEPARIN INDUCED PLATELET ANTIBODY WAS ELEVATED, AS WAS PTT. STOPPING BOTH HIS ANTIBIOTIC REGIMEN AND THE ENOXAPARIN RESULTED IN AN IMPROVED COUNT ABOUT 11 DAYS LATER (75,000). SYMPTOMS: 1. THROMBOCYTOPENIA. DATES OF USE 2007. EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED? 1. YES. 2. YES #4. DIAGNOSIS OR REASON FOR USE. LONG-TERM ABX USE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 HEPARIN 100 UNITS QUID IV NZW

    Patients

    Seq Age Sex Outcome Treatment
    1 67 YR Hospitalization ENOXAPRIN 40MG ONCE SQ DVT PROPHYLAXIS